108 related articles for article (PubMed ID: 8140471)
1. [Myasthenia].
Gajdos P
Soins; 1993 Nov; (578):35-7. PubMed ID: 8140471
[No Abstract] [Full Text] [Related]
2. Pharmacology of myasthenia gravis.
Dipalma JR
Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
[No Abstract] [Full Text] [Related]
3. Biology of myasthenia gravis.
Lindstrom J; Dau P
Annu Rev Pharmacol Toxicol; 1980; 20():337-62. PubMed ID: 6992700
[No Abstract] [Full Text] [Related]
4. The pharmacological basis for the treatment of myasthenia gravis.
Flacke W
Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
[No Abstract] [Full Text] [Related]
5. Rational therapy of myasthenia gravis.
Finley JC; Pascuzzi RM
Semin Neurol; 1990 Mar; 10(1):70-82. PubMed ID: 2189183
[No Abstract] [Full Text] [Related]
6. Electrophysiological and clinical correlation in myasthenia gravis.
Oh SJ; Eslami N; Nishihira T; Sarala PK; Kuba T; Elmore RS; Sunwoo IN; Ro YI
Ann Neurol; 1982 Oct; 12(4):348-54. PubMed ID: 7149660
[No Abstract] [Full Text] [Related]
7. [Current status of the physiopathology and treatment of myasthenia gravis].
Vázquez A; Fernández O
Rev Clin Esp; 1978 May; 149(4):321-6. PubMed ID: 694105
[No Abstract] [Full Text] [Related]
8. Myasthenia gravis accompanied with hypokalemic periodic paralysis.
Sawanyawisuth K; Tiamkao S; Pratipanawatr T
J Med Assoc Thai; 2006 May; 89(5):727-9. PubMed ID: 16756062
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis.
Lott RS
J Am Pharm Assoc; 1973 Aug; 13(8):444-50. PubMed ID: 4354762
[No Abstract] [Full Text] [Related]
10. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
Nigrovic V; Amann A; Bhatt S
Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
12. Patient and family fact sheet. Myasthenia gravis: maximizing function.
Kernich CA
Neurologist; 2008 Jan; 14(1):75-6. PubMed ID: 18195664
[No Abstract] [Full Text] [Related]
13. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
[No Abstract] [Full Text] [Related]
14. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
Brown JC; Johns RJ
Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
[No Abstract] [Full Text] [Related]
15. Myasthenia gravis.
Quick DT
Int Anesthesiol Clin; 1968; 6(1):261-8. PubMed ID: 5704462
[No Abstract] [Full Text] [Related]
16. The management of myasthenia gravis.
Preswick G
Acta Med Philipp; 1966; 2(3):157-8. PubMed ID: 5915027
[No Abstract] [Full Text] [Related]
17. Management of myasthenia gravis.
Lazar A
J Assoc Physicians India; 1991 Aug; 39(8):655. PubMed ID: 1814893
[No Abstract] [Full Text] [Related]
18. The treatment of myasthenia gravis.
Hofmann WW
Ration Drug Ther; 1979 Feb; 13(2):1-8. PubMed ID: 472321
[No Abstract] [Full Text] [Related]
19. Myasthenia gravis. Emergency treatment.
Kennedy WR
Minn Med; 1968 Sep; 51(9):1291-3. PubMed ID: 5679230
[No Abstract] [Full Text] [Related]
20. Crisis, precrisis and drug resistance in myasthenia gravis.
Glaser GH
Ann N Y Acad Sci; 1966 Jan; 135(1):335-49. PubMed ID: 5221348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
